Tag results:
osteosarcoma cells
Mesenchymal Cell News
AMTB, a TRPM8 Antagonist, Suppresses Growth and Metastasis of Osteosarcoma through Repressing the TGFβ Signaling Pathway
[Cell Death & Disease] Investigators found that N-(3-aminopropyl)-2-[(3-methylphenyl) methoxy]-N-(2-thienylmethyl) benzamide hydrochloride (AMTB) suppressed osteosarcoma cell proliferation, metastasis and induced cellular apoptosis.
Cancer Stem Cell News
Local Anesthetic Levobupivacaine Inhibits Stemness of Osteosarcoma Cells by Epigenetically Repressing MAFB Though Reducing KAT5 Expression
[Aging] Scientists identified that the treatment of levobupivacaine suppressed proliferation of osteosarcoma cells in vitro.
Endothelial Cell News
Bevacizumab Attenuates Osteosarcoma Angiogenesis by Suppressing MIAT Encapsulated by Serum-Derived Extracellular Vesicles and Facilitating miR-613-Mediated GPR158 Inhibition
[Cell Death & Disease] Scientists investigated the therapeutic potential of bevacizumab in angiogenesis during osteosarcoma and the related mechanisms.
Mesenchymal Cell News
Bone Mesenchymal Stem Cell-Derived Extracellular Vesicles Containing NORAD Promote Osteosarcoma by miR-30c-5p
[Laboratory Investigation] Investigators explored the role of non-coding RNA activated by DNA damage (NORAD) derived from extracellular vesicles of bone MSCs in osteosarcoma.
Extracellular Matrix News
3D Bioprinting of Multifunctional Dynamic Nanocomposite Bioinks Incorporating Cu-Doped Mesoporous Bioactive Glass Nanoparticles for Bone Tissue Engineering
[Small] Investigators developed a multifunctional nanocomposite bioink based on amine-functionalized copper-doped mesoporous bioactive glass nanoparticles and a hydrogel formulation that improved shape fidelity, and structural stability for extrusion-based bioprinting.
Mesenchymal Cell News
Rho-GEF Trio Regulates Osteosarcoma Progression and Osteogenic Differentiation through Rac1 and RhoA
[Cell Death & Disease] Investigators found that Trio was highly expressed in osteosarcoma than normal tissues and promoted the proliferation, migration, and invasion of osteosarcoma cells.